AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

Completed · Phase 2 · Has a placebo group

Conditions studied: Autism Spectrum Disorder (ASD)

In brief

The purpose of this study is to establish the potential benefits, safety, and tolerability of AB-2004 in participants with irritability associated with autism spectrum disorder.

Key facts

Study ID
NCT04895215
Run by
Vertero Therapeutics
People needed
156
Starts
2021-08-02
Expected to finish
2023-12-15
Last updated by the study team
2025-11-21

Who can join

Age: 5 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.